Mehmet Saluvan

Sr. Staff Scientist

Boston Children's Hospital
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (10)

Coronavirus disease 2019 (COVID-19) poses significant risks for solid organ transplant recipients, who have atypical but poorly characterized immune responses to infection. We aim to understand the host immunologic and microbial features of COVID-19 in transplant recipients by leveraging a prospective multicenter cohort of 86 transplant recipients age- and sex-matched with 172 non-transplant controls. We find that transplant recipients have higher nasal SARS-CoV-2 viral abundance and impaired viral clearance, and lower anti-spike IgG levels. In addition, transplant recipients exhibit decreased plasmablasts and transitional B cells, and increased senescent T cells. Blood and nasal transcriptional profiling demonstrate unexpected upregulation of innate immune signaling pathways and increased levels of several proinflammatory serum chemokines. Severe disease in transplant recipients, however, is characterized by a less robust induction of pro-inflammatory genes and chemokines. Together, our study reveals distinct immune features and altered viral dynamics in solid organ transplant recipients.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Post-acute sequelae of SARS-CoV-2 (PASC) is a significant public health concern. We describe Patient Reported Outcomes (PROs) on 590 participants prospectively assessed from hospital admission for COVID-19 through one year after discharge. Modeling identified 4 PRO clusters based on reported deficits (minimal, physical, mental/cognitive, and multidomain), supporting heterogenous clinical presentations in PASC, with sub-phenotypes associated with female sex and distinctive comorbidities. During the acute phase of disease, a higher respiratory SARS-CoV-2 viral burden and lower Receptor Binding Domain and Spike antibody titers were associated with both the physical predominant and the multidomain deficit clusters. A lower frequency of circulating B lymphocytes by mass cytometry (CyTOF) was observed in the multidomain deficit cluster. Circulating fibroblast growth factor 21 (FGF21) was significantly elevated in the mental/cognitive predominant and the multidomain clusters. Future efforts to link PASC to acute anti-viral host responses may help to better target treatment and prevention of PASC.

Year:

2024

The glycosylation of IgG plays a critical role during human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and inducing cytokine production. However, the role of IgM N-glycosylation has not been studied during human acute viral infection. The analysis of IgM N-glycosylation from healthy controls and hospitalized coronavirus disease 2019 (COVID-19) patients reveals increased high-mannose and sialylation that correlates with COVID-19 severity. These trends are confirmed within SARS-CoV-2-specific immunoglobulin N-glycan profiles. Moreover, the degree of total IgM mannosylation and sialylation correlate significantly with markers of disease severity. We link the changes of IgM N-glycosylation with the expression of Golgi glycosyltransferases. Lastly, we observe antigen-specific IgM antibody-dependent complement deposition is elevated in severe COVID-19 patients and modulated by exoglycosidase digestion. Taken together, this work links the IgM N-glycosylation with COVID-19 severity and highlights the need to understand IgM glycosylation and downstream immune function during human disease.

Year:

2024

Age is a major risk factor for severe coronavirus disease 2019 (COVID-19), yet the mechanisms behind this relationship have remained incompletely understood. To address this, we evaluated the impact of aging on host immune response in the blood and the upper airway, as well as the nasal microbiome in a prospective, multicenter cohort of 1031 vaccine-naïve patients hospitalized for COVID-19 between 18 and 96 years old. We performed mass cytometry, serum protein profiling, anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays, and blood and nasal transcriptomics. We found that older age correlated with increased SARS-CoV-2 viral abundance upon hospital admission, delayed viral clearance, and increased type I interferon gene expression in both the blood and upper airway. We also observed age-dependent up-regulation of innate immune signaling pathways and down-regulation of adaptive immune signaling pathways. Older adults had lower naïve T and B cell populations and higher monocyte populations. Over time, older adults demonstrated a sustained induction of pro-inflammatory genes and serum chemokines compared with younger individuals, suggesting an age-dependent impairment in inflammation resolution. Transcriptional and protein biomarkers of disease severity differed with age, with the oldest adults exhibiting greater expression of pro-inflammatory genes and proteins in severe disease. Together, our study finds that aging is associated with impaired viral clearance, dysregulated immune signaling, and persistent and potentially pathologic activation of pro-inflammatory genes and proteins.

Year:

2024

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized by highly heterogeneous manifestations ranging from asymptomatic cases to death for still incompletely understood reasons. As part of the IMmunoPhenotyping Assessment in a COVID-19 Cohort study, we mapped the plasma proteomes of 1117 hospitalized patients with COVID-19 from 15 hospitals across the United States. Up to six samples were collected within ~28 days of hospitalization resulting in one of the largest COVID-19 plasma proteomics cohorts with 2934 samples. Using perchloric acid to deplete the most abundant plasma proteins allowed for detecting 2910 proteins. Our findings show that increased levels of neutrophil extracellular trap and heart damage markers are associated with fatal outcomes. Our analysis also identified prognostic biomarkers for worsening severity and death. Our comprehensive longitudinal plasma proteomics study, involving 1117 participants and 2934 samples, allowed for testing the generalizability of the findings of many previous COVID-19 plasma proteomics studies using much smaller cohorts.

Year:

2024

Year:

2023

Year:

2023

Collaborators (32)

Holden T. Maecker

Stanford University School of Medicine

UNITED STATES
View details

Suzanna Chak

University of California, San Francisco

UNITED STATES
View details

Elsio Wunder

Assistant Professor

University of Connecticut

UNITED STATES
View details

Slim Fourati

Assistant Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Bali Pulendran

Emory University

UNITED STATES
View details

Hanno Steen

Professor

Harvard Medical School

UNITED STATES
View details

Justin Rousseau

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Samuel Yang

Faculty

Stanford University

UNITED STATES
View details

Joann Diray Arce

Assistant Professor

Boston Children's Hospital

UNITED STATES
View details

Alvin Kho

Assistant Professor

Harvard University

UNITED STATES
View details

Ramin Salehi-Rad

UCLA

UNITED STATES
View details

Christian Bime

Professor of Medicine

University of Arizona

UNITED STATES
View details

Catherine Blish

Association Professor

Stanford University School of Medicine

UNITED STATES
View details

Ruth Montgomery

Professor

Yale University School of Medicine

UNITED STATES
View details

Scott Brakenridge

Professor

University of Washington

UNITED STATES
View details

Michael Wilson

Professor

University of California, San Francisco

UNITED STATES
View details

Harry Pickering

Assistant Professor

UCLA Health

UNITED STATES
View details

Cole Maguire

University of Texas at Austin

UNITED STATES
View details

Harm van Bakel

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Elaine F. Reed

University of California

UNITED STATES
View details

Nadine Rouphael

Professor with Tenure

Emory University

UNITED STATES
View details

Al Ozonoff

Associate Professor

Harvard University

UNITED STATES
View details

Linda N. Geng

Stanford University

UNITED STATES
View details

Lekshmi Santhosh

Associate Professor

University of California

UNITED STATES
View details

Aleksandra Leligdowicz

Assistant Professor

University of Western Ontario

CANADA
View details

Chris Cotsapas

Professor

Yale University School of Medicine

UNITED STATES
View details

Oscar Alberto Aguilar-Alfaro

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Mary Ann Comunale

Assistant Professor

Drexel University College of Medicine

UNITED STATES
View details

Hiromitsu Asashima

University of Tsukuba

JAPAN
View details

Michele Kutzler

Professor of Medicine and Microbiology and Immunology

Drexel University

UNITED STATES
View details

Boryana Petrova

Head of Research Metabolomics

Medical University of Vienna

AUSTRIA
View details

Erin Scherer

Associate Professor

Emory University

UNITED STATES
View details